US Pres. Trump: Vaccine may be approved `very, very soon'
|During his press conference on early Wednesday in Asia, US President Donald Trump rekindled hopes of the coronavirus (COVID-19) vaccine while citing an agreement with Kodak.
Key quotes
Historic agreement being reached with Kodak to produce critical pharmaceuticals.
DPA being used to give $675 million loan to launch Kodak pharmaceuticals.
The US government deal with Kodak for pharmaceutical ingredients is his 33rd use of the defense production act.
Vaccine may be approved "very,very soon".
Pfizer's vaccine is going in the right direction.
Today's action is our latest step to create the greatest medical arsenal in history.
Coronavirus numbers will be going down soon.
We will make America the world's premier medical manufacturer and supplier.
Not a single American who has needed a ventilator has been denied a ventilator.
We'll have 500 million doses of a COVID-19 vaccine.
Perhaps we'll be supplying" other parts of the world with the vaccine.
The pharmaceutical arm of Kodak will make "general, active pharmaceutical ingredients" that are the "key starting materials that are the building blocks for many drug.
Some aspects of Republican coronavirus relief bill that do not support. (Doesn't specify the details.)
Think hydroxychloroquine works in the early stages of infection.
For the most part, the administration has done what Dr. Fauci and coronavirus task force coordinator BIRX have recommended.
Going to take care of the people' when asked about expiring federal unemployment benefits.
FX implications
The news confronts the previous downbeat news, suggesting a further delay in the US fiscal package, which in turn helped AUD/USD remain afloat in the middle of the 0.7100.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.